Abstract
Rationale: The coexistence of osteoporosis/osteopenia, sarcopenia and obesity has been described as osteosarcopenic obesity, resulting in reduced functionality and systemic metabolic dysregulation. Our objective was to determine the prevalence of sarcopenic obesity (SO), osteopenic obesity (OO) and osteosarcopenic obesity (OSO).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
